BMS-820836 for Depression
This study is completed in the United Kingdom, in Spain, in Austria, .... It is testing BMS-820836 for Depression.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United Kingdom, in Spain, in Austria, .... It is testing BMS-820836 for Depression.
In United KingdomThis study is completed in France, in the United Kingdom, in Belgium, .... It focuses on ADHD.
In United KingdomThis study is completed in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study is ongoing in the United Kingdom. It is testing Multiple Oral Doses of TAK-831 for Schizophrenia.
In United KingdomThis study is completed in the United Kingdom and in Germany. It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In United KingdomThis study was terminated in the United Kingdom, in Czechia, and in Poland. It focuses on schizophrenia.
In United KingdomThis study is completed in the United Kingdom and in Spain. It focuses on depression.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.
In United KingdomThis study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.